blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4281101

EP4281101 - INTERLEUKIN-2 MUTANTS AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  27.10.2023
Database last updated on 30.10.2024
FormerThe international publication has been made
Status updated on  29.07.2022
Formerunknown
Status updated on  04.03.2022
Most recent event   Tooltip11.06.2024New entry: Decision on request for further processing 
Applicant(s)For all designated states
Visterra, Inc.
275 2nd Avenue, 4th Floor
Waltham, MA 02451 / US
[2023/48]
Inventor(s)01 / CARLSON, Scott, Moore
Waltham, MA 02451 / US
02 / BABCOCK, Gregory
Waltham, MA 02451 / US
03 / SHRIVER, Zachary
Waltham, MA 02451 / US
04 / RAMAKRISHNAN, Boopathy
Waltham, MA 02451 / US
05 / SLOAN, Susan
Waltham, MA 02451 / US
 [2023/48]
Representative(s)Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
[2023/48]
Application number, filing date22705612.420.01.2022
[2023/48]
WO2022US13141
Priority number, dateUS202163139736P20.01.2021         Original published format: US 202163139736 P
US202163281397P19.11.2021         Original published format: US 202163281397 P
[2023/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022159590
Date:28.07.2022
Language:EN
[2022/30]
Type: A1 Application with search report 
No.:EP4281101
Date:29.11.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 28.07.2022 takes the place of the publication of the European patent application.
[2023/48]
Search report(s)International search report - published on:EP28.07.2022
ClassificationIPC:A61K38/20, A61P13/12, A61P37/00, C07K14/55, C07K16/24
[2023/48]
CPC:
A61P13/12 (EP,KR,US); C07K14/55 (EP,KR); A61K38/2013 (EP,US);
A61P37/00 (EP); A61P37/06 (KR,US); C12N5/0637 (EP,KR,US);
A61K38/00 (KR); C07K2319/30 (EP,KR); C12N2501/2302 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/48]
Extension statesBA13.07.2023
ME13.07.2023
TitleGerman:INTERLEUKIN-2-MUTANTEN UND VERWENDUNGEN DAVON[2023/48]
English:INTERLEUKIN-2 MUTANTS AND USES THEREOF[2023/48]
French:MUTANTS D'INTERLEUKINE-2 ET LEURS UTILISATIONS[2023/48]
Entry into regional phase13.07.2023National basic fee paid 
13.07.2023Designation fee(s) paid 
13.07.2023Examination fee paid 
Examination procedure13.07.2023Examination requested  [2023/48]
13.07.2023Date on which the examining division has become responsible
02.04.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
31.05.2024Amendment by applicant (claims and/or description)
Request for further processing for:31.05.2024Request for further processing filed
31.05.2024Full payment received (date of receipt of payment)
Request granted
10.06.2024Decision despatched
Fees paidRenewal fee
24.01.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[ID]WO2016164937  (AMGEN INC [US]);
 [A]US2020325201  (HIGGINSON-SCOTT NATHAN [US], et al);
 [XDP]WO2021021606  (VISTERRA INC [US])
by applicantEP0125023
 EP0171496
 EP0173494
 WO8601533
 EP0184187
 GB2188638
 US4816567
 WO9002809
 EP0388151
 WO9100906
 WO9110741
 WO9117271
 WO9201047
 WO9203918
 WO9203917
 WO9209690
 WO9215679
 WO9218619
 WO9220791
 EP0519596
 WO9301288
 US5223409
 US5225539
 WO9404678
 US5585089
 US5624821
 US5648260
 US5693761
 US5693762
 WO2016164937
 US2018037634
 WO2018052556
 US2021024601
 WO2021021606
 WO1986US02269
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.